Navigation Links
Kedem Pharmaceuticals Engages a FDA Compliant Contract Formulation Development Company for the Production of KDM-1102 Clinical Materials
Date:1/4/2012

s, pain killers, migraine, anti-allergy medications, cardiovascular diseases, lung medications, and addiction replacement therapies.

About Corealis Pharma Inc. is a private Montreal based contractual formulation development and clinical supply manufacturing company of pharmaceutical oral solid dosage forms for United-States, European, and Canadian trials (www.corealispharma.com).

Forward-looking Statement

This press release includes forward-looking statements that involve a number of risks and uncertainties, including the success of the products in commercializing and developing. Additionally this press release include statement within the meaning of the Private Securities Litigation Reform  Act of 1995, that are subject to high risks, uncertainties and other factors, including that the Regulatory Agencies may not agree to the claims made in the Company documents related to our products, and product development. There are risks that due to unforeseen reasons, matters could cause the actual results to differ materially from those referred in our fillings. Risks involved patent infringement, trademark and other commercially related actions that hinder the product development and marketing. Additional risks involve the ability of the Company to raise capital to fund its operations and the capital requirements for the development and marketing of its products. Investors are encouraged to review the risk factors listed or described from time to time in the Company's filings (10K) with the Securities and Exchange Commission, as well as to obtain independent third party opinions before investing in the Company's securities. 

For further information, contact:
Kedem Investor Relations 1 866 465-6551
info@kedempharmaceuticals.com

Or

Kelly Black
Premier Media Services 1 480 649 8224
'/>"/>

SOURCE Kedem Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Merz Pharmaceuticals Receives J-Code For Xeomin® (incobotulinumtoxinA)
2. Quark Pharmaceuticals Reports Favorable Interim Results from Phase I Clinical Study of QPI-1007 in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
3. Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy
4. Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. MAP Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
6. Jazz Pharmaceuticals to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Transaction
7. Radient Pharmaceuticals Announces Reverse Stock Split
8. Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
9. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Endo Pharmaceuticals to Present at J.P. Morgan 30th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015 Delcath Systems, Inc. (NASDAQ: ... focused on oncology with an emphasis on the treatment ... for the three months ended March 31, 2015.  ... weeks include: , Achieved quarterly product revenue of ... with the first quarter of 2014; , Activated ...
(Date:5/6/2015)... YORK , May 6, 2015  Integrative ... activation and patient-reported outcomes for chronic pain, depression, ... released by The Bravewell Collaborative . ... the Patients Receiving Integrative Medicine Interventions Effectiveness Registry ... Using data from PRIMIER , ...
(Date:5/6/2015)... The Parenteral Drug Association (PDA) Board of ... Richard M. Johnson to continue as President ... pleased to have Richard Johnson continue as ... the Chair of the Board of Directors. "Under Richard,s ... has led a strong staff and dedicated volunteers, hosting ...
Breaking Medicine Technology:Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2
... Aug. 22, 2011 Prasco Laboratories, the Authorized Generics ... Shionogi Inc . Under the terms of ... distribute Nitrofurantoin Oral Suspension, the Authorized Generic version of Furadantin® ... the U.S. under the Prasco label. "Prasco ...
... 22, 2011 Etymotic Research , an ... launch of the GunSport*PRO line of high-definition electronic ... and professional shooters, the GunSport*PRO allows users to ... ears from sudden, loud blasts.  The GunSport*PRO is ...
Cached Medicine Technology:Prasco® Launches Authorized Generic with Shionogi Inc. 2Etymotic Debuts GunSport*PRO High Definition Electronic Earplugs 2
(Date:5/6/2015)... May 05, 2014 (PRWEB) May 06, 2015 ... Lock accepted, on behalf of MEBC, an Alliance ... from JDA Software during FOCUS 2015, JDA’s annual ... across the manufacturing, retail and wholesale distribution sectors. ... that their clients are receiving services that advance ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Beryl ... 1 of Patient Experience Journal (PXJ), an international, ... practices around understanding and improving patient experience. The second ... patient experience conversation globally, helps align the voices engaged ... , Published in association with The Beryl Institute, ...
(Date:5/6/2015)... Angeles (PRWEB) May 06, 2015 ... the #1 ranked international water, sanitation and hygiene nonprofit ... for communities across the world and it brings our ... Carnett, CEO of Marketing Maven. “The ongoing relationship between ... opportunities available for people to learn about and support ...
(Date:5/6/2015)... 06, 2015 Wolters Kluwer , ... and students, announced today that in a survey of ... use of the clinical decision support resource improves the ... of 2014, UpToDate users in more than 170 countries ... month, on average. In Germany alone, 95% of all ...
(Date:5/6/2015)... has opened press registration for TU-Automotive Detroit as the ... headlines of major publications world-wide. With 150+ speakers from ... to share their visions for the future of connected ... to go behind the scenes and hear major automakers’ ... year we’re releasing a preview of all the major ...
Breaking Medicine News(10 mins):Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Press Registration for TU-Automotive Detroit Now Open 2
... , HOUSTON, Aug. 6 US Oncology, Inc. ("US ... reported revenue of $881.6 million, EBITDA of $39.9 million, Adjusted EBITDA of $62.7 ... for the three months ended June 30, 2009. , , ... , Adjusted EBITDA for the second quarter of ...
... , WALTHAM, Mass., Aug. 6 ... and advisory firms for pharmaceutical and healthcare issues, today ... which now includes patient share and sales forecasts through ... disodium (R788). The report update is based on Rigel ...
... , , , , ... it,s easy for their owners to get caught up in work, family ... for regular annual exams. In a recent national survey conducted in ... than one-third of respondents claimed to only bring their cats to the ...
... , , , -Window ... , , NEW YORK, Aug. 6 The ... EHE International to raise awareness of the fight against Parkinson,s disease. For ... space at 10 Rockefeller Plaza to showcase the many ways that ordinary ...
... , SOUTH SAN FRANCISCO, Calif., Aug. 6 ... of drug discovery and development through the application of cellular reprogramming, ... Hochedlinger to the company,s Scientific Advisory Board (SAB). , , ... cell research and their addition to the iPierian SAB rounds out ...
... , ATLANTA, Aug. 6 Although ... vacation, it is actually exam time here in Georgia. Don,t fret, the ... office instead of the traditional classroom, and should take place before or ... a routine doctor,s exam to confirm that all immunizations are up-to-date, a ...
Cached Medicine News:Health News:US Oncology Reports Second Quarter Operating Results 2Health News:US Oncology Reports Second Quarter Operating Results 3Health News:US Oncology Reports Second Quarter Operating Results 4Health News:US Oncology Reports Second Quarter Operating Results 5Health News:US Oncology Reports Second Quarter Operating Results 6Health News:US Oncology Reports Second Quarter Operating Results 7Health News:US Oncology Reports Second Quarter Operating Results 8Health News:US Oncology Reports Second Quarter Operating Results 9Health News:US Oncology Reports Second Quarter Operating Results 10Health News:US Oncology Reports Second Quarter Operating Results 11Health News:US Oncology Reports Second Quarter Operating Results 12Health News:US Oncology Reports Second Quarter Operating Results 13Health News:US Oncology Reports Second Quarter Operating Results 14Health News:US Oncology Reports Second Quarter Operating Results 15Health News:US Oncology Reports Second Quarter Operating Results 16Health News:US Oncology Reports Second Quarter Operating Results 17Health News:US Oncology Reports Second Quarter Operating Results 18Health News:US Oncology Reports Second Quarter Operating Results 19Health News:US Oncology Reports Second Quarter Operating Results 20Health News:US Oncology Reports Second Quarter Operating Results 21Health News:US Oncology Reports Second Quarter Operating Results 22Health News:US Oncology Reports Second Quarter Operating Results 23Health News:US Oncology Reports Second Quarter Operating Results 24Health News:US Oncology Reports Second Quarter Operating Results 25Health News:Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium 2Health News:Feline Pine Announces National 'Take Your Cat to the Vet Day' August 22 2Health News:EHE International Supports The Michael J. Fox Foundation for Parkinson's Research 2Health News:iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board 2Health News:Is it Exam Time for Georgia's School Children Already? 2Health News:Is it Exam Time for Georgia's School Children Already? 3Health News:Is it Exam Time for Georgia's School Children Already? 4
... The Finnpipette BioControl ... innovative features as the ... universal handle fits all ... single channel tip cone ...
... The Research pro Electronic Pipette is ideal ... laboratory. Its easy-to-follow display, ergonomically-placed operating buttons, ... dispensing, reverse pipetting and diluting make this ... simple functions of a manual pipette without ...
... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
Medicine Products: